BioTrends Research Group Releases Non-Small-Cell Lung Cancer Report Findings
One hundred and five US-based medical oncologists were surveyed about their current and expected treatment patterns in one of the largest oncology indications.
Read MorePosted by Clinical Lab Products | Apr 24, 2012 | Cancer, Miscellaneous, Pancreatic |
One hundred and five US-based medical oncologists were surveyed about their current and expected treatment patterns in one of the largest oncology indications.
Read MorePosted by Clinical Lab Products | Apr 20, 2012 | Cancer, Miscellaneous |
The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer patients treated with the combination therapy bevacizumab plus erlotinib.
Read MorePosted by Clinical Lab Products | Apr 17, 2012 | Cancer, Miscellaneous |
FDA has granted two 510(k) clearances for QIAGEN NVs real-time PCR instrument Rotor-Gene Q MDx and a compatible test for the detection of Influenza A/B, the artus Infl A/B RG RT-PCR Kit, for IVD.
Read MorePosted by Clinical Lab Products | Apr 11, 2012 | Molecular Diagnostics |
SeraCare Life Sciences IncBiocare MedicalRubicon Genomics IncRandox Toxicology LtdQuest DiagnosticsVentana Medical Systems IncAdvanDx
Read MorePosted by Clinical Lab Products | Mar 23, 2012 | Cancer, Miscellaneous |
MSKCC and IBM have agreed to development of a tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices.
Read More